3 Factor Indexing’s Halozyme HALO Stock Holding History

3 Factor Indexing’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$157	Hold	2	–	–	﹤0.01%	333
2026 Q1	$130	Buy	+2	New	+$141	﹤0.01%	360

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

3 Factor Indexing's HALO Position: Q2 2026 in Review

3 Factor Indexing held its Halozyme (HALO) position steady in Q2 2026 at 2 shares worth $157. The position accounts for ﹤0.01% of the portfolio, ranked #333.

3 Factor Indexing first reported a position in HALO in Q1 2026 and has held it in 2 quarters since. 629 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

3 Factor Indexing held 2 shares of Halozyme worth $157 as of Q2 2026.
3 Factor Indexing left its Halozyme share count unchanged in Q2 2026.
Halozyme made up ﹤0.01% of 3 Factor Indexing's portfolio in Q2 2026, its #333 holding.
3 Factor Indexing first reported a position in Halozyme in Q1 2026 and has held it in 2 quarters since.
629 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on 3 Factor Indexing's 13F filing for Q2 2026, filed 8 Jul 2026.